Horizon Therapeutics (HZNP) option IV into confirms in deal discussions

Horizon Therapeutics (NASDAQ: HZNP) December call option implied volatility is at 47, January is at 43; compared to its 52-week range of 31 to 100 into the Board of Horizon Therapeutics confirms that it is engaged in highly preliminary discussions with Amgen (AMGN), Janssen Global Services (JNJ), and Sanofi (SNY). Call put ratio 2.2 calls to 1 put.

You May Also Be Interested In

• Oracle (ORCL) call put ratio 2.3 calls to 1 put with a focus on October calls into quarter results
• Oracle (ORCL) call put ratio 2.7 calls to 1 put with a focus on September 11 weekly 165 calls into quarter results
• Teucrium Wheat Fund (WEAT) call put ratio 12 calls to 1 put amid sharp rally